1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Biologics Development
  6.  » Systematic LC/MS/MS Investigations for the IND-Enabling Extended Characterization of Antibody–Drug Conjugate Modifications

Systematic LC/MS/MS Investigations for the IND-Enabling Extended Characterization of Antibody–Drug Conjugate Modifications

Summary: ADCs are an important class of biologic drugs that are well-represented in clinical trials for oncology and other indications. These medicines harbor both chemical and post-translational modifications (PTMs) that require characterization and provide strong challenges for platform analytical methods that were built to address more traditional, less-complicated molecular formats, such as monoclonal antibodies. This article published in the Journal Antibodies outlines a method for investigational new drug (IND)-enabling extended characterization for ADCs.

Click here to download article.

Related Topics